New hope for kids facing dangerous chemo side effect
NCT ID NCT04195347
Summary
This study is testing whether a new drug called CM4620 can safely reduce the severity of a serious pancreas inflammation (acute pancreatitis) that sometimes occurs in children and young adults receiving a specific chemotherapy drug (asparaginase) for leukemia. Researchers will give CM4620 by IV infusion shortly after pancreatitis symptoms begin and monitor patients for about four months to see if it prevents severe complications. The goal is to find a safe dose and see if the drug helps control this painful and potentially dangerous side effect of cancer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PANCREATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Novant Health Presbyterian Hemby Children's Hospital
RECRUITINGCharlotte, North Carolina, 28204, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
St. Jude Children's Research Hospital
RECRUITINGMemphis, Tennessee, 38105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.